-
Scientific rationale
The THINK HADRON 2025 meeting aims to explore the state of the art in the diagnosis and treatment of these rare malignancies, with a focus on the integration of advanced imaging, molecular profiling, and emerging treatment modalities, including hadrontherapy. In this context, the role of collaborative networks, national and international, becomes fundamental to ensure adequate patient management, data sharing, and access to highly specialized treatments. -
How to participate the meeting
Per favorire la partecipazione, questo evento si svolgerà in forma ibrida. Sarà possibile seguire l’attività formativa in presenza presso la sede congressuale o in remoto.
I due pulsanti sottostanti permettono di iscriversi secondo la modalità desiderata, fino ad esaurimento dei posti disponibili. L’iscrizione all’attività potrà avvenire esclusivamente attraverso procedura online, non saranno accettati nuovi iscritti presso la sede congressuale.
ISCRIVITI al Corso Residenziale - PAVIA ISCRIVITI all'Evento Digitale - ONLINE -
Programme
9.00 Opening remarks by the Authorities Gianluca Vago 9.15 Introduction to the meeting Session I Moderatore: Patrizia Morbini 9.20 Sinonasal cancer as a paradigm of the role of collaborative networks in the management of rare tumors Annalisa Trama 9.40 The broad spectrum of sinonasal tumors: histological and biological heterogeneity Alessandro Franchi 10.10 Diagnostic and predictive imaging Antonello Vidiri 10.30 Q&A and Discussion All the Speakers 10.50 Coffee break Session II Moderatori: Giovanni Succo, Luca Volpi 11.20 Orbital preservation surgical strategies Marco Ferrari 11.35 How to guide post-operative radiotherapy in sinonasal cancer Florent Carsuzaa 11.50 The role of salvage surgery Iacopo Dallan 12.05 Q&A and Discussion Session III Moderatori: Elisa D'angelo, Lisa Francesca Linda Licitra 12.20 Histology and molecular driven systemic therapy Paolo Bossi 12.35 New clinical trial: Neopesino Laura Deborah Locati 12.50 How to select patients and who should receive particle therapy? Anna Maria Camarda 13.05 Radiation-induced toxicity Sandra Nuyts 13.20 Neurological, neuropsychological and advanced MRI assessment of brain toxicity after hadrontherapy for skull base and paranasal sinuses cancers: radiomic and dosomic analysis Guido Baroni 13.35 Q&A and Discussion All the speakers 13.45 Light Lunch Session IV Moderatore: Giuseppe Sanguineti Group Workshop 14.30 - Clinical cases presentation
Alberto Daniele Arosio, Sara Demurtas, Sara Ronchi 15.00 - Multidisciplinary Team work (3 clinical cases will be discussed by each group that includes at least one surgical oncologist, one radiation oncologist and one medical oncologist)
Tutor: Laura Deborah Locati 15.50 Coffee break
During the break, results from the groups will be briefly analyzed16.15 Group workshop results presentation Tutor: Laura Deborah Locati 16.30 Panel Discussion. Tumor Board Experts Panelists:
Pierluigi Bonomo, Paolo Bossi, Florent Carsuzaa, Iacopo Dallan, Lisa Francesca Linda Licitra, Laura Deborah Locati, Davide Mattavelli, Patrizia Morbini, Sandra Nuyts, Antonello Vidiri, Barbara Vischioni17.40 Closing remarks Laura Deborah Locati -
Faculty
Ester Orlandi Pavia Alberto Daniele Arosio Varese Guido Baroni Milano Pierluigi Bonomo Firenze Paolo Bossi Rozzano (MI) Anna Maria Camarda Pavia Florent Carsuzaa Poitiers (Francia) Elisa D'angelo Bologna Iacopo Dallan Pisa Sara Demurtas Pavia Marco Ferrari Padova Alessandro Franchi Pisa Lisa Francesca Linda Licitra Milano Laura Deborah Locati Pavia Davide Mattavelli Brescia Patrizia Morbini Genova Sandra Nuyts Leuven (Belgio) Sara Ronchi Pavia Giuseppe Sanguineti Roma Giovanni Succo Candiolo (TO) Annalisa Trama Milano Antonello Vidiri Roma Barbara Vischioni Pavia Luca Volpi Varese
